Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Patients can now use AI to monitor their glucose levels with off-the-shelf, noninvasive wearable sensors, according to a new study published in Scientific Reports.
Radiomics and machine learning can help healthcare providers determine if late gadolinium enhancement (LGE) on cardiac MR images is a sign of myocardial infarction (MI) or myocarditis.
Deep learning could potentially assist healthcare providers with the evaluation of small renal masses detected on certain contrast-enhanced CT exams, according to a new study published in the American Journal of Roentgenology.
Machine learning (ML) technology has gained popularity in recent years, but its use in healthcare remains largely limited to proof-of-concept academic studies, according to a new study published in Artificial Intelligence in Medicine.
Researchers have developed a deep learning system capable of evaluating tissue samples and diagnosing prostate cancer at a level comparable with many pathologists.
